Rankings
▼
Calendar
SNDX Q3 2016 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$305,000
Gross Profit
$305,000
100.0% margin
Operating Income
-$15M
-4996.1% margin
Net Income
-$15M
-4907.9% margin
EPS (Diluted)
$-0.84
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$12M
Stock-Based Comp.
$792,000
Balance Sheet
Total Assets
$118M
Total Liabilities
$24M
Stockholders' Equity
$94M
Cash & Equivalents
$13M
← FY 2016
All Quarters
Q4 2016 →
